Glenmark Pharmaceuticals (India)

273 papers and 3.5k indexed citations i.

About

In recent decades, authors affiliated with Glenmark Pharmaceuticals (India) have published 273 papers, which have received a total of 3.5k indexed citations. Scholars at this organization have produced 63 papers in Epidemiology, 51 papers in Pulmonary and Respiratory Medicine and 44 papers in Pharmacology on the topics of Congenital Heart Disease Studies (24 papers), Nail Diseases and Treatments (21 papers) and Asthma and respiratory diseases (20 papers). Their work is cited by papers focused on Molecular Biology (634 citations), Organic Chemistry (536 citations) and Epidemiology (517 citations). Authors at Glenmark Pharmaceuticals (India) collaborate with scholars in India, United States and United Kingdom and have published in prestigious journals including Journal of Biological Chemistry, Journal of Clinical Oncology and Blood. Some of Glenmark Pharmaceuticals (India)'s most productive authors include Bharat Dalvi, Hanmant Barkate, Neelima Khairatkar-Joshi, A Szállaśi, Saiprasad Patil, Prajak J. Barde, Laxmikant A. Gharat, Robin Pinto, Shashank Joshi and Agam Vora.

In The Last Decade

Fields of papers published by authors at Glenmark Pharmaceuticals (India)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Glenmark Pharmaceuticals (India) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Glenmark Pharmaceuticals (India) at the time of their publication.

Countries citing scholars working at Glenmark Pharmaceuticals (India)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Glenmark Pharmaceuticals (India). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Glenmark Pharmaceuticals (India) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenmark Pharmaceuticals (India) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025